These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28615145)

  • 61. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
    Oppert M; Schindler R; Husung C; Offermann K; Gräf KJ; Boenisch O; Barckow D; Frei U; Eckardt KU
    Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Abrupt versus gradual cessation of steroids in patients with septic shock.
    Sobolewski KA; Brophy A; Opsha Y; Zaid A; Mistry N
    J Crit Care; 2018 Dec; 48():198-202. PubMed ID: 30232056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determinants of Outcome in Burn ICU Patients with Septic Shock.
    Lavrentieva A; Voutsas V; Konoglou M; Karali V; Koukiasa P; Loridas N; Papaioannou M; Vasileiadou G; Bitzani M
    J Burn Care Res; 2017; 38(1):e172-e179. PubMed ID: 27003623
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.
    McDonnell E; Collins R; Hernandez M; Brown ART
    J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose corticosteroids in septic shock: Has the pendulum shifted?
    Lemieux SM; Levine AR
    Am J Health Syst Pharm; 2019 Apr; 76(8):493-500. PubMed ID: 30851043
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
    Huang H; Wu C; Shen Q; Xu H; Fang Y; Mao W
    Am J Emerg Med; 2021 Oct; 48():203-208. PubMed ID: 33975132
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do We Need to Administer Fludrocortisone in Addition to Hydrocortisone in Adult Patients With Septic Shock? An Updated Systematic Review With Bayesian Network Meta-Analysis of Randomized Controlled Trials and an Observational Study With Target Trial Emulation.
    Lai PC; Lai CH; Lai EC; Huang YT
    Crit Care Med; 2024 Apr; 52(4):e193-e202. PubMed ID: 38156911
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
    Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
    Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnosis of corticosteroid insufficiency in Thai patients with septic shock.
    Ratanarat R; Promsin P; Srivijitkamol A; Leemingsawat C; Permpikul C
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S187-95. PubMed ID: 20364574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous use of traditional Chinese medicine (si-ni-tang) to treat septic shock patients: study protocol for a randomized controlled trial.
    Chen HC; Chen WC; Lin KH; Chen YH; Lo LC; Lee TC; Hsia TC; Wang CH; Wu SH; Hsu HW; Chang YJ; Huang YC; Ku TH; Horng MH
    Trials; 2011 Aug; 12():199. PubMed ID: 21864392
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tolerability of Enteral Nutrition in Mechanically Ventilated Patients With Septic Shock Who Require Vasopressors.
    Merchan C; Altshuler D; Aberle C; Papadopoulos J; Schwartz D
    J Intensive Care Med; 2017 Oct; 32(9):540-546. PubMed ID: 27377392
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
    Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
    Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort.
    Dargent A; Nguyen M; Fournel I; Bourredjem A; Charles PE; Quenot JP;
    Shock; 2018 Jun; 49(6):625-630. PubMed ID: 29040212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.
    Póvoa P; Salluh JI; Martinez ML; Guillamat-Prats R; Gallup D; Al-Khalidi HR; Thompson BT; Ranieri VM; Artigas A
    Crit Care; 2015 Apr; 19(1):193. PubMed ID: 25928214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of Low-Dose Hydrocortisone on the Incidence of Atrial Fibrillation in Patients With Septic Shock: A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study.
    Launey Y; Lasocki S; Asehnoune K; Gaudriot B; Chassier C; Cinotti R; Maguet PL; Laksiri L; Mimoz O; Tawa A; Nesseler N; Malledant Y; Perrot B; Seguin P
    J Intensive Care Med; 2019 Mar; 34(3):238-244. PubMed ID: 28292220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.